Business · 19/01/2017
FDA Releases Draft Guidance on Communications with Payors and Formulary Committees
The FDA has published a draft guidance document addressing common questions about healthcare economic information and investigational products, aiming to provide clarity for pharmaceutical companies and payors.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →